Terbinafine Hydrochloride
Product Images NDC 55648-743

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 55648-743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container Label (Terbinafinehcltab Figure 01)

Container Label (Terbinafinehcltab Figure 01)
This is a description for a drug called Terbinafine hydrochloride. Each tablet contains 250 mg of Terbinafine base. The recommended adult dosage is available in the package insert. It needs to be stored in a tight container, protected from light, at a temperature between 20°C-25°C (68°F-77°F). The drug is manufactured by Wockhardt Limited and distributed by Wockhardt USA LLC. The location of manufacturing is Mumbai, India, and the distribution center is in Parsippany, NJ 07054.*
FDA Label Image

Structure (Terbinafinehcltab Figure 02)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.